While only a handful of chemical companies are typically discussed as pesticides producers (e.g. Bayer, Monsanto, Syngenta, Dow and DuPont), there was considerable diversity beyond these companies. While the prominent companies do market a large number of products, a large number of other minor companies also produced a considerable number of products While regulators will be aware of all formulation/adjuvant compositions, their capacity to investigate and regulate is limited by both funding and legislative prerogative. So, the diversity revealed here could potentially overextend regulatory bodies capacity to effectively regulate pesticide products. This could put non-target organisms like human users, consumer and wildlife at risk. Another concern is whether regulators have the appropriate testing protocols to detect formulation to formulation differences in toxicity , with fewer products regulators would have greater capacity for individual investigation of any one product. Beyond pesticide formulations, adjuvants largely persist under the radar of regulators, academics and other interested parties. So, while effective adjuvant components and adjuvants are less numerous than that of active ingredients, there is still considerable diversity and potential for unintended toxicity which deserves further exploration.